FOLOTYN pralatrexate injection 20 mg/mL, 1mL vial (USA)
Section 19A approved medicine
FOLOTYN pralatrexate injection 20 mg/mL, 1mL vial (USA)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Current
Medicines in short supply/unavailable
FOLOTYN pralatrexate 20 mg/1 mL injection, intravenous infusion vial - ARTG 192493
Indication(s)
FOLOTYN is indicated for the treatment of adult patients with peripheral T-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.
Images
